Ayurveda Market Size, Share & Trends Analysis Report By Form (Herbal, Mineral, Herbomineral), By Application (Medical/Therapy, Personal), By Indication, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2026 - 2033

Ayurveda Market Summary

The global ayurveda market size was valued at USD 20.42 billion in 2025 and is expected to reach USD 85.83 billion by 2033, growing at a CAGR of 19.72% from 2026 to 2033. This growth is largely due to the rising prevalence of chronic diseases, increasing awareness of Ayurvedic benefits, and strong adoption and acceptance of Ayurveda across consumer groups.

Growing demand for organic and natural personal care products that use Ayurvedic ingredients such as neem, turmeric and sandalwood is also strengthening industry expansion. A key market trend involves clinical studies that highlight the health benefits of Ayurvedic supplements, which have increased scientific validation, boosted consumer trust and supported wider market uptake. Ayurvedic medicines and treatments are further preferred for their comparatively lower side effects than allopathy. For instance, from September to October 2024, the Journal of Research in Ayurvedic Sciences published an editorial explaining that centuries of empirical Ayurveda should be reassessed using rigorous scientific methods, including experimental, clinical, observational, systematic review and meta-analysis designs. The authors noted that this approach could help address psoriasis, hypertension, obesity, diabetes and musculoskeletal disorders more effectively.

For instance, Turmeric is widely used in various supplements due to its anti-inflammatory properties, which have been validated by research. The market witnessed a surge in demand due to the increasing consumer focus on preventive healthcare and immunity-boosting products during the COVID-19 pandemic. The lockdowns and social distancing measures led to a shift in consumer behavior towards natural and organic products, including Ayurvedic supplements and medicines. Moreover, the growing awareness about the benefits of Ayurveda in managing stress and anxiety levels also contributed to the market growth during COVID-19. Governments around the world are recognizing the potential benefits of Ayurveda and are taking steps to regulate and promote its use.

For instance, in India, the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy) has been established to promote traditional medicine and alternative medicine systems. According to the Directorate General of Commercial Intelligence and Statistics (DGCI&S), India's exports of Ayurvedic and herbal products have increased from USD 479.6 million (3,967.4 crores INR) in FY21 to USD 606.2 million (5,014.3 crores INR) in FY23. On the other hand, the import of Ayurvedic and herbal products in India has also increased USD 71.4 million (590.7 crores INR) in FY21 to USD 91.1 million (753.8 crores INR) in FY23, with a compound annual growth rate of 13 %. As a result, India's trade surplus in Ayurvedic and herbal products increased from 408.2 million (3,376.7 crore INR in FY21 to USD 515.1 million (4,260.5 crore INR) in FY23.

Global Ayurveda Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033s. For this study, Grand View Research has segmented the global Ayurveda market report based on form, application, indications, distribution channel, end use, and region:

• Form Outlook (Revenue, USD Million, 2021 - 2033)
• Herbal
• Mineral
• Herbomineral
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Medical/Therapy
• Personal
• Indications Outlook (Revenue, USD Million, 2021 - 2033)
• GI Tract
• Infectious Diseases
• Skin/Hair
• Respiratory System
• Nervous System
• Cardiovascular System
• Reproductive System
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Direct Sales
• E-sales
• Retail & Institutional Sales
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Home Settings
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Norway
• Sweden
• Denmark
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa (MEA)
• South Africa
• South Arabia
• UAE
• Kuwait

Please note The report will be delivered in 2-3 business days upon order notification. Show more